Future Tools for Improved Cancer Surgery: From Prototype to Clinical Use
| Reference number | |
| Coordinator | Navari Surgical AB |
| Funding from Vinnova | SEK 996 000 |
| Project duration | November 2024 - June 2025 |
| Status | Ongoing |
| Venture | Acceleration of deep tech companies |
| Call | Acceleration of deep tech companies 2024 |
Purpose and goal
Navari is a startup founded through an interdisciplinary collaboration between Chalmers University and Sahlgrenska University Hospital. Navari´s technology, ARVIS, is the world’s first augmented reality (AR) tool that can be used in real time during surgery, targeting the market segment for minimally invasive surgery for soft tissue cancer. With this project, Navari aims to move from its current prototype stage to market, where ARVIS can create clinical value for surgeons in their daily work.
Expected effects and result
Upon project completion, the goal is for Navari to have successfully developed an initial product targeting the market segment of liver cancer through clinical studies, CE-marking, and initial sales.
Planned approach and implementation
A brief overview of all planned stages for the project is provided below: Stage 1 - Product ready for a second preclinical study Stage 2 - Product ready for clinical study Stage 3 - Compilation of technical file for CE marking Stage - 4 Initial sales to customers in pilot projects